An AI medical imaging tool that helps radiologists and healthcare providers triage chest X-rays for TB and pneumonia-related abnormalities in high-volume settings.
RADIFY AI is a web-based AI medical imaging tool for radiologists, public hospitals, and private practices that assists with detecting and triaging abnormalities on chest X-rays, including TB and pneumonia-related findings.
Key capabilities include:
Available on Web.
Targeted at B2B healthcare providers, including radiologists and imaging teams in public hospitals, private practices, emergency rooms, ICUs, and point-of-care settings (including portable X-ray use cases and routine monitoring for patients with mild symptoms).
Notable in the African market context, the product is licensed by SAHPRA as a Class A Medical Device and has FDA 510(k) clearance for triaging Pneumothorax and Pleural Effusion, supporting deployment in regulated clinical environments, including high-burden TB regions such as South Africa.
No reviews yet. Be the first to review this product.
DD Dave found that RADIFY AI has raised $1.7M across 1 round, backed by 1 investor. Their latest round was a Venture (Round not Specified) in Feb 2023. See how we get product data
Breet — Crypto & Stablecoins Payment API for African Businesses 
Promptmonitor — Track, measure, and improve how AI recommends your brand. 
Promptmonitor